Evidence map›Paper›PMID 22479615›Full record

ArticlePloS one2012

Hedgehog signaling in tumor cells facilitates osteoblast-enhanced osteolytic metastases.

Shamik Das, J Allan Tucker, Shikha Khullar, Rajeev S Samant, Lalita A Shevde

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. What Is Breast in the Bone?International journal of molecular sciences · 2016
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Role of osteopontin in the pathophysiology of cancer.Matrix biology : journal of the International Society for Matrix Biology · 2014
    Review
  20. Emerging targeted agents in metastatic breast cancer.Nature reviews. Clinical oncology · 2013
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Shamik DasDepartment of Oncologic Sciences, USA-Mitchell Cancer Institute, University of South Alabama, Mobile, Alabama, United States of America.
J Allan Tucker
Shikha Khullar
Rajeev S Samant
Lalita A Shevde
University of South Alabama · USUSA Mitchell Cancer Institute · US

Funding

Role of Nmi in retarding breast tumor growth.R01CA140472 · NCI · UNIVERSITY OF SOUTH ALABAMA · PI SAMANT, RAJEEV S · 2010 to 2014
$1.3M
NCI NIH HHS 1R01CA140472-01A1NCI NIH HHS R01 CA140472
6 · The paper itself

Abstract

The remodeling process in bone yields numerous cytokines and chemokines that mediate crosstalk between osteoblasts and osteoclasts and also serve to attract and support metastatic tumor cells. The metastatic tumor cells disturb the equilibrium in bone that manifests as skeletal complications. The Hedgehog (Hh) pathway plays an important role in skeletogenesis. We hypothesized that the Hh pathway mediates an interaction between tumor cells and osteoblasts and influences osteoblast differentiation in response to tumor cells. We have determined that breast tumor cells have an activated Hh pathway characterized by upregulation of the ligand, IHH and transcription factor GLI1. Breast cancer cells interact with osteoblasts and cause an enhanced differentiation of pre-osteoblasts to osteoblasts that express increased levels of the osteoclastogenesis factors, RANKL and PTHrP. There is sustained expression of osteoclast-promoting factors, RANKL and PTHrP, even after the osteoblast differentiation ceases and apoptosis sets in. Moreover, tumor cells that are deficient in Hh signaling are compromised in their ability to induce osteoblast differentiation and consequently are inefficient in causing osteolysis. The stimulation of osteoblast differentiation sets the stage for osteoclast differentiation and overall promotes osteolysis. Thus, in the process of developing newer therapeutic strategies against breast cancer metastasis to bone it would worthwhile to keep in mind the role of the Hh pathway in osteoblast differentiation in an otherwise predominant osteolytic phenomenon.

Indexed as

AnimalsBreastBreast NeoplasmsCell LineCell Line, TumorFemaleGene Expression Regulation, NeoplasticHedgehog ProteinsHumansMiceMice, NudeNeoplasm MetastasisOncogene ProteinsOsteoblastsOsteolysisSignal TransductionHedgehog ProteinsIHH protein, humanOncogene ProteinsTrans-ActivatorsZinc Finger Protein GLI1

Identifiers

PMID22479615
PMCPMC3315536
OpenAlexW1992019708

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.